ECSP13012650A - Métodos y composiciones para tratar diarrea asociada con vih - Google Patents
Métodos y composiciones para tratar diarrea asociada con vihInfo
- Publication number
- ECSP13012650A ECSP13012650A ECSP13012650A ECSP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A EC SP13012650 A ECSP13012650 A EC SP13012650A
- Authority
- EC
- Ecuador
- Prior art keywords
- diarrhea
- methods
- hiv
- compositions
- diarrhea associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Se plantean en la presente métodos para tratar diarrea al administrar a un paciente en necesidad del mismo, un inhibidor de transporte de iones de cloruro en una cantidad suficiente para tratar diarrea. El tratamiento de diarrea incluye el tratamiento de diarrea así como el dolor, molestia abdominal y otros síntomas asociados con diarrea. En una modalidad, el inhibidor de transporte de iones de cloruro es crofelemer.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40862210P | 2010-10-31 | 2010-10-31 | |
US40933510P | 2010-11-02 | 2010-11-02 | |
US41624910P | 2010-11-22 | 2010-11-22 | |
US201161434379P | 2011-01-19 | 2011-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP13012650A true ECSP13012650A (es) | 2013-10-31 |
Family
ID=45994461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP13012650 ECSP13012650A (es) | 2010-10-31 | 2013-05-31 | Métodos y composiciones para tratar diarrea asociada con vih |
Country Status (19)
Country | Link |
---|---|
US (4) | US8962680B2 (es) |
EP (1) | EP2632550B1 (es) |
JP (2) | JP6063385B2 (es) |
CN (2) | CN107595836A (es) |
AU (1) | AU2011320155B2 (es) |
BR (1) | BR112013010774A2 (es) |
CA (1) | CA2816416C (es) |
DK (1) | DK2632550T3 (es) |
EC (1) | ECSP13012650A (es) |
ES (1) | ES2635435T3 (es) |
HK (1) | HK1249036A1 (es) |
HU (1) | HUE035393T2 (es) |
MX (1) | MX348184B (es) |
PE (1) | PE20140036A1 (es) |
PL (1) | PL2632550T3 (es) |
PT (1) | PT2632550T (es) |
RU (1) | RU2597746C2 (es) |
WO (1) | WO2012058664A1 (es) |
ZA (1) | ZA201303136B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007248183B2 (en) | 2006-05-01 | 2013-08-01 | Napo Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer |
US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
SI2241318T1 (sl) | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
PT2632550T (pt) | 2010-10-31 | 2017-08-02 | Napo Pharmaceuticals Inc | Métodos e composições para tratar diarreia associada a vih |
MX2015007065A (es) * | 2012-12-07 | 2017-03-01 | Napo Pharmaceuticals Inc | Metodo y composiciones para tratar diarrea asociada con vih. |
US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
JOP20190275A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج اضطراب إسهال خِلقي |
JOP20190276A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة |
EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
CA3182864A1 (en) * | 2020-06-19 | 2021-12-23 | Lisa A. CONTE | Methods and compositions for treating chemotherapy-induced diarrhea |
WO2022115481A1 (en) * | 2020-11-24 | 2022-06-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating post-acute infection gastrointestinal disorders |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
ATE430477T1 (de) | 1996-10-16 | 2009-05-15 | Napo Pharmaceuticals Inc | Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe |
WO2000047062A2 (en) | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
US20040071793A1 (en) | 2002-10-05 | 2004-04-15 | Bobrowski Paul J. | Oral rehydration methods and compositions |
WO2005074575A2 (en) * | 2004-01-30 | 2005-08-18 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
AU2006262275A1 (en) * | 2005-06-22 | 2007-01-04 | The Massachusetts Institute Of Technology | HIV-1 protease inhibitors, and methods of making and using them |
WO2007068383A1 (en) | 2005-12-15 | 2007-06-21 | Bayer Healthcare Ag | Diaryl ureas for treating virus infections |
SI2241318T1 (sl) | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
AU2007248183B2 (en) | 2006-05-01 | 2013-08-01 | Napo Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer |
US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
US20100092479A1 (en) | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US7928115B2 (en) | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
EA023814B1 (ru) | 2009-08-26 | 2016-07-29 | Гленмарк Фармасьютикалс Лтд. | Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм |
JP2013506716A (ja) * | 2009-10-06 | 2013-02-28 | ザ レゲンツ オブ ジ ユニヴァーシティ オブ カリフォルニア | クロフェレマーなどのプロアントシアニジンオリゴマーを用いて疾患を治療する方法 |
US20110087530A1 (en) | 2009-10-09 | 2011-04-14 | Visa U.S.A. Inc. | Systems and Methods to Provide Loyalty Programs |
PT2632550T (pt) | 2010-10-31 | 2017-08-02 | Napo Pharmaceuticals Inc | Métodos e composições para tratar diarreia associada a vih |
RU2593014C2 (ru) | 2011-01-27 | 2016-07-27 | Гленмарк Фармасьютикалс Лимитед | Способ производства проантоцианидиновой полимерной композиции |
RU2014124981A (ru) | 2011-12-22 | 2016-02-10 | Гленмарк Фармасьютикалс Лимитед | Неэнтеросолюбильная фармацевтическая композиция, содержащая крофелемер |
MX2015007065A (es) | 2012-12-07 | 2017-03-01 | Napo Pharmaceuticals Inc | Metodo y composiciones para tratar diarrea asociada con vih. |
-
2011
- 2011-10-31 PT PT118372499T patent/PT2632550T/pt unknown
- 2011-10-31 WO PCT/US2011/058549 patent/WO2012058664A1/en active Application Filing
- 2011-10-31 ES ES11837249.9T patent/ES2635435T3/es active Active
- 2011-10-31 JP JP2013536904A patent/JP6063385B2/ja active Active
- 2011-10-31 PL PL11837249T patent/PL2632550T3/pl unknown
- 2011-10-31 CA CA2816416A patent/CA2816416C/en active Active
- 2011-10-31 BR BR112013010774A patent/BR112013010774A2/pt not_active Application Discontinuation
- 2011-10-31 RU RU2013123794/15A patent/RU2597746C2/ru active
- 2011-10-31 DK DK11837249.9T patent/DK2632550T3/en active
- 2011-10-31 CN CN201711077144.7A patent/CN107595836A/zh active Pending
- 2011-10-31 CN CN2011800637391A patent/CN103370101A/zh active Pending
- 2011-10-31 US US13/285,397 patent/US8962680B2/en active Active
- 2011-10-31 AU AU2011320155A patent/AU2011320155B2/en active Active
- 2011-10-31 MX MX2013004873A patent/MX348184B/es active IP Right Grant
- 2011-10-31 EP EP11837249.9A patent/EP2632550B1/en active Active
- 2011-10-31 HU HUE11837249A patent/HUE035393T2/en unknown
- 2011-10-31 PE PE2013000926A patent/PE20140036A1/es not_active Application Discontinuation
- 2011-11-11 US US13/294,307 patent/US20120107370A1/en not_active Abandoned
-
2013
- 2013-04-29 ZA ZA2013/03136A patent/ZA201303136B/en unknown
- 2013-05-31 EC ECSP13012650 patent/ECSP13012650A/es unknown
-
2014
- 2014-06-17 US US14/307,175 patent/US20140294903A1/en not_active Abandoned
-
2015
- 2015-01-15 US US14/597,740 patent/US9585868B2/en active Active
-
2016
- 2016-08-02 JP JP2016151656A patent/JP6310971B2/ja active Active
-
2018
- 2018-07-09 HK HK18108819.2A patent/HK1249036A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2816416C (en) | 2020-02-11 |
HUE035393T2 (en) | 2018-05-02 |
ZA201303136B (en) | 2016-01-27 |
ES2635435T3 (es) | 2017-10-03 |
HK1249036A1 (zh) | 2018-10-26 |
JP2013540826A (ja) | 2013-11-07 |
MX2013004873A (es) | 2013-08-21 |
AU2011320155B2 (en) | 2016-02-25 |
JP2017019806A (ja) | 2017-01-26 |
RU2597746C2 (ru) | 2016-09-20 |
PE20140036A1 (es) | 2014-01-31 |
US20150190367A1 (en) | 2015-07-09 |
JP6310971B2 (ja) | 2018-04-11 |
US9585868B2 (en) | 2017-03-07 |
JP6063385B2 (ja) | 2017-01-18 |
PL2632550T3 (pl) | 2017-10-31 |
PT2632550T (pt) | 2017-08-02 |
WO2012058664A1 (en) | 2012-05-03 |
AU2011320155A1 (en) | 2013-05-09 |
US20140294903A1 (en) | 2014-10-02 |
US20120184605A1 (en) | 2012-07-19 |
US8962680B2 (en) | 2015-02-24 |
EP2632550B1 (en) | 2017-05-03 |
US20120107370A1 (en) | 2012-05-03 |
CN103370101A (zh) | 2013-10-23 |
CN107595836A (zh) | 2018-01-19 |
BR112013010774A2 (pt) | 2017-03-21 |
RU2013123794A (ru) | 2014-12-10 |
EP2632550A4 (en) | 2014-04-23 |
EP2632550A1 (en) | 2013-09-04 |
MX348184B (es) | 2017-06-02 |
CA2816416A1 (en) | 2012-05-03 |
DK2632550T3 (en) | 2017-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012650A (es) | Métodos y composiciones para tratar diarrea asociada con vih | |
ECSP15030799A (es) | Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y métodos de tratamiento con los mismos | |
CR20140410A (es) | Esketamina para el tratamiento de la depresión refractaria al tratamiento o resistente al tratamiento | |
ECSP12012106A (es) | Terapia antiviral | |
NZ602219A (en) | Methods and compositions for treating degos’ disease | |
MD4577C1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
EA201201186A1 (ru) | ИСПОЛЬЗОВАНИЕ ErbB3 ИНГИБИТОРОВ В ЛЕЧЕНИИ ТРИЖДЫ НЕГАТИВНОГО И БАЗАЛЬНО-ПОДОБНОГО ВИДОВ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ | |
CR11724A (es) | Agente para tratar enfermedades | |
NI201400112A (es) | Tratamiento del cáncer con inhibidores tor cinasa | |
AR087918A1 (es) | Tratamientos combinados que comprenden antagonistas de c-met y antagonistas de b-raf | |
ECSP13012551A (es) | Terapia de combinación para tratar infección por hcv. | |
BR112014019350A8 (pt) | Composição terapêutica estéril, seu uso para tratar diarreia induzida por rotavírus e embalagem | |
DOP2013000131A (es) | Composiciones y métodos para tratar el cáncer usando un inhibidor de pi3k y un inhibidor de mek | |
MX2015007065A (es) | Metodo y composiciones para tratar diarrea asociada con vih. | |
CO6731081A2 (es) | Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol | |
TR200900879A2 (tr) | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler | |
CO6670518A2 (es) | Tratamiento de infecciones de clostridium difícile en pacientes bajo terapia con antibióticos | |
MY180772A (en) | Novel therapeutic mirtazapine combinations for use in pain disorders | |
CO6771411A2 (es) | Metodos y composiciones para tratar diarrea asociada al vih | |
GT201400071A (es) | Combinación terapéutica para el tratamiento de cáncer | |
BR112022025741A2 (pt) | Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid) | |
EA201491836A1 (ru) | Способы лечения рака с использованием ингибитора pi3k и ингибитора mek | |
AR092169A1 (es) | Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla | |
CL2022003634A1 (es) | Métodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia. | |
CR20160116A (es) | Método para tratar onicomicosis con hidroxipropil quitasano |